These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis. Shah PL, Scott SF, Knight RA, Hodson ME. Eur Respir J; 1996 Mar; 9(3):531-4. PubMed ID: 8730015 [Abstract] [Full Text] [Related]
30. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME. N Engl J Med; 1994 Sep 08; 331(10):637-42. PubMed ID: 7503821 [Abstract] [Full Text] [Related]
31. Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis. Sanders NN, Franckx H, De Boeck K, Haustraete J, De Smedt SC, Demeester J. Thorax; 2006 Nov 08; 61(11):962-8. PubMed ID: 17071834 [Abstract] [Full Text] [Related]
32. CPAP has no effect on clearance, sputum properties, or expectorated volume in cystic fibrosis. Aquino ES, Shimura F, Santos AS, Goto DM, Coelho CC, de Fuccio MB, Saldiva PH, Lorenzi-Filho G, Rubin BK, Nakagawa NK. Respir Care; 2012 Nov 08; 57(11):1914-9. PubMed ID: 22417659 [Abstract] [Full Text] [Related]
39. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis. Shak S. Chest; 1995 Feb 08; 107(2 Suppl):65S-70S. PubMed ID: 7842816 [Abstract] [Full Text] [Related]
40. DNA and actin bind and inhibit interleukin-8 function in cystic fibrosis sputa: in vitro effects of mucolytics. Perks B, Shute JK. Am J Respir Crit Care Med; 2000 Nov 08; 162(5):1767-72. PubMed ID: 11069810 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]